Each month of delay meant thousands of preventable deaths.
Em meados de junho de 2021, pesquisadores da USP e da Unesp colocaram sobre a mesa um cálculo difícil de ignorar: cada mês de vacinação lenta no Brasil corresponde a 20 mil mortes que poderiam ter sido evitadas. A ciência, mais uma vez, não oferecia consolo — oferecia uma escolha. Nove estados já haviam decidido não esperar, antecipando seus calendários na esperança de que a velocidade pudesse fazer o que a hesitação não fez.
- O estudo revelou que o ritmo vacinação praticado nos três meses anteriores custou ao Brasil 60 mil vidas que poderiam ter sido salvas.
- A urgência é concreta: chegar a 2 milhões de doses diárias até o fim de agosto ainda poderia evitar 30 mil mortes adicionais.
- São Paulo antecipou seu calendário em 30 dias, mirando a primeira dose em toda a população adulta até 15 de setembro — uma corrida contra o próprio tempo.
- Ao menos nove estados, do Pará ao Rio Grande do Sul, já romperam com o ritmo federal e aceleraram por conta própria.
- O ponto frágil permanece o mesmo: tudo depende de que as remessas de vacinas do Programa Nacional de Imunizações cheguem conforme prometido.
Uma pesquisa divulgada em junho de 2021 por cientistas da USP e da Unesp trouxe um número que pesava mais do que estatística: se o Brasil tivesse vacinado mais rápido nos três meses anteriores, 60 mil pessoas ainda estariam vivas. O estudo analisou dados do primeiro trimestre do ano e projetou cenários até agosto, concluindo que aplicar 2 milhões de doses por dia poderia evitar 20 mil mortes mensais.
O matemático Wallace Casaca foi direto ao ponto: mesmo partindo do ritmo lento que havia prevalecido, sustentar esse novo patamar até o fim de agosto ainda salvaria cerca de 30 mil vidas. A lógica era simples; a execução, não.
São Paulo reagiu anunciando uma antecipação de 30 dias no calendário de vacinação, com meta de aplicar a primeira dose em toda a população adulta até 15 de setembro — 7,5 milhões de pessoas a mais dentro de um prazo comprimido. A coordenadora do programa estadual fez questão de sublinhar que o plano estava ancorado em remessas confirmadas pelo governo federal, reconhecendo que o abastecimento continuava sendo o elo mais frágil da cadeia.
O movimento de São Paulo não era exceção. Ao menos outros oito estados já haviam antecipado seus cronogramas: Pará, Rio Grande do Sul e Goiás miravam setembro; Ceará, agosto; Rio de Janeiro, Espírito Santo, Alagoas e Santa Catarina, outubro. O que emergia era um padrão de descentralização — estados decidindo não aguardar um ritmo federal e avançando dentro dos limites do estoque disponível.
Para os especialistas em saúde pública, a pesquisa traduzia em números o que já se sabia em princípio: vacinação em massa, rápida e contínua, era o único caminho comprovado para sair da pandemia. A pergunta que ficava no ar era se a aceleração em curso chegaria a tempo — e se as vacinas prometidas chegariam junto.
Two universities in São Paulo released research in mid-June 2021 showing that Brazil could prevent 20,000 deaths from COVID-19 each month if the country accelerated its vaccination pace to two million doses per day. The study, conducted by researchers at the University of São Paulo and the State University of São Paulo, analyzed vaccination data from the first quarter of the year and projected outcomes through August. What the numbers revealed was sobering: had Brazil maintained a faster vaccination rhythm over the previous three months, 60,000 lives could have been spared.
Wallace Casaca, a data scientist and mathematician involved in the research, explained the stakes plainly. If the National Immunization Program could sustain an injection rate of two million doses daily through the end of August, the country could still prevent 30,000 deaths—roughly 10,000 per month—even accounting for the slow pace at which vaccination capacity had been building. The math was straightforward, but the execution remained the harder problem.
São Paulo's state government responded to the research by announcing it would accelerate its vaccination calendar by 30 days, aiming to administer first doses to the entire adult population by September 15. The state planned to vaccinate 7.5 million people under this compressed timeline. Nora Regiane de Paula, who coordinates the state's immunization program, noted that the acceleration was built on confirmed vaccine shipments from the federal program—a crucial caveat, since supply remained a persistent constraint.
The São Paulo move was not isolated. At least nine states across Brazil had already moved their vaccination schedules forward by the time the research became public. Beyond São Paulo itself, Pará, Rio Grande do Sul, and Goiás all aimed to complete first-dose coverage of adults by September. Ceará pushed even harder, targeting the end of August. Rio de Janeiro, Espírito Santo, Alagoas, and Santa Catarina set their completion dates for October.
The pattern suggested a shift in how state governments were approaching the crisis. Rather than waiting for a centralized timeline, they were working within the constraints of available supply to move faster than the federal pace would have allowed. Whether this decentralized acceleration could be sustained depended entirely on whether vaccine shipments arrived as promised and whether the infrastructure to administer doses could keep pace with the supply.
For public health experts, the message was clear: mass vaccination, executed quickly and consistently, remained the only proven path out of the pandemic. The research gave that principle a quantifiable weight—each month of delay at the old pace meant thousands of preventable deaths. The question was whether the acceleration now underway could be maintained long enough to matter.
Notable Quotes
If we can apply up to two million doses per day by the end of August, we could prevent 30,000 deaths in Brazil, or about 10,000 per month.— Wallace Casaca, data scientist and mathematician at USP/Unesp
The Hearth Conversation Another angle on the story
Why does this study matter now, in June 2021? Wasn't Brazil already vaccinating people?
Brazil was vaccinating, but slowly. The research showed that the pace was costing lives—literally thousands per month that could have been prevented. It gave a number to what had been a vague sense of urgency.
Two million doses a day sounds like a lot. Was that realistic?
It was ambitious, but not impossible. The study was built on real vaccination data from earlier in the year, so the researchers knew what the system had already achieved. The question was whether states could sustain that pace with the vaccine supply they were promised.
Why did nine states suddenly move their schedules up?
The research gave them cover to act faster than the federal government was moving. If you can show that acceleration saves lives, and you have the doses coming in, why wait? It became a competitive thing—states racing to protect their populations.
What about the people who couldn't get vaccinated even if the pace accelerated?
The study assumed the vaccines would reach people. That's a big assumption in a country as large and unequal as Brazil. Infrastructure matters as much as supply.
Did this actually change anything?
It shifted the conversation. Before, slow vaccination was treated as inevitable. After, it was treated as a choice with a body count attached. That changes how politicians talk about the problem.